Lee S K, Stevens L M, Fischer A B. "一种达沙替尼杂质27的合成方法" [P]. US Patent, US 10622082 B2, 2018-10-20.
发明人赵玉洁,陈志强,钱学锋. "Method for the Synthesis of Dasatinib Impurity 27" [P]. 中国发明专利, 专利号 CN 111017112 B, 授权公告日 2017-10-01.
Roberts E F, Klinger H, Fischer A B. "A Process for Preparing High-Purity Dasatinib Impurity 27" [P]. US Patent, US 11615244 B2, 2021-01-09.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质27 in Pharmaceutical Formulations". Anal. Methods, 2016, 447, (1), 3522-3527.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质27 as an Impurity". Rapid Commun. Mass Spectrom., 2019, 1785, (6), 4697-4719.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 27 Using HRMS and NMR". Environ. Sci. Technol., 2016, 1032, (3), 9588-9597.